Companies: 10,795·Total market cap: $144.5T

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc.

RPHMNASDAQHealthcare

$18.20

+$16.47(+952.02%)

Market Cap$60840416

P/E Ratio—

52W High$82.9

52W Low$1.68

Avg Volume17K

Open$1.68

Beta0.22

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Reneo Pharmaceuticals, Inc.（RPHM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RPHM · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Reneo Pharmaceuticals, Inc. 数据

分析师预测$— · Buy

股息不分红

分析师评级与目标价

Buy7 位分析师

Strong Buy

0

Buy

4

Hold

3

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$18.20Current

$—Avg Target

$—High

合计: 7 · 买入占比: 57.1%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Reneo Pharmaceuticals, Inc.

$18.20+952.02%$60.8M #2

Achilles Therapeutics plc

$1.48+0.68%$60.8M #3

$9.81+4.14%$49.5M #4

Heat Biologics, Inc.

$2.38+0.42%$61.1M #5

Kronos Bio, Inc.

$0.88+1.49%$53.7M #6

Quince Therapeutics, Inc.

$1.00+0.11%$5.6M

关于 Reneo Pharmaceuticals, Inc.

CEOGregory J. Flesher

IPO DateApr 8, 2021

Employees8

CountryUS

Websitereneopharma.com

Reneo Pharmaceuticals, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to creating therapies for individuals suffering from uncommon inherited mitochondrial disorders. Th…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Reneo Pharmaceuticals, Inc.（RPHM）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 8, 2021 在 NASDAQ 上市。截至最近交易日，RPHM 股价为 $18.20，市值约为 $60.8M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Reneo Pharmaceuticals, Inc.（RPHM）股价为 $18.20，在 NASDAQ 上市，52周区间为 $1.68 – $82.90。

RPHM 最新股价RPHM quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议